Robert E. Bancroft - Apr 29, 2025 Form 4 Insider Report for AEON Biopharma, Inc. (AEON)

Role
President & CEO, Director
Signature
/s/ Alexander Wilson, as attorney-in-fact for Robert E. Bancroft
Stock symbol
AEON
Transactions as of
Apr 29, 2025
Transactions value $
$0
Form type
4
Date filed
5/1/2025, 04:50 PM
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AEON Stock Option Award $0 +59K $0.00 59K Apr 29, 2025 Class A Common Stock 59K $0.41 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vest on each anniversary measured from April 29, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.